Solriamfetol Hydrochloride
CAS 178429-62-4 1 FDA-DMF supplierSmall Molecule
Overview
Solriamfetol Hydrochloride is a norepinephrine-dopamine reuptake inhibitor that is indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. It is known for its effects in enhancing the neurotransmission processes within the central nervous system, promoting alertness.
Therapeutic areas
NarcolepsyObstructive Sleep Apnea
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.